Gladstone Institutional Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Sell |
12,937
-1,935
| -13% | -$32.4K | 0.01% | 694 |
|
|
2025
Q1 | $229K | Sell |
14,872
-139,377
| -90% | -$2.14M | 0.01% | 653 |
|
|
2024
Q4 | $3.4M | Buy |
154,249
+10,310
| +7% | +$227K | 0.16% | 154 |
|
|
2024
Q3 | $2.59M | Buy |
143,939
+128,748
| +848% | +$2.32M | 0.13% | 185 |
|
|
2024
Q2 | $247K | Sell |
15,191
-150
| -1% | -$2.44K | 0.01% | 579 |
|
|
2024
Q1 | $216K | Buy |
15,341
+1,180
| +8% | +$16.7K | 0.01% | 592 |
|
|
2023
Q4 | $148K | Buy |
14,161
+575
| +4% | +$6K | 0.01% | 636 |
|
|
2023
Q3 | $139K | Hold |
13,586
| – | – | 0.01% | 588 |
|
|
2023
Q2 | $102K | Hold |
13,586
| – | – | 0.01% | 612 |
|
|
2023
Q1 | $120K | Sell |
13,586
-989
| -7% | -$8.75K | 0.01% | 628 |
|
|
2022
Q4 | $133K | Hold |
14,575
| – | – | 0.01% | 614 |
|
|
2022
Q3 | $118K | Hold |
14,575
| – | – | 0.01% | 606 |
|
|
2022
Q2 | $110K | Sell |
14,575
-128
| -0.9% | -$966 | 0.01% | 620 |
|
|
2022
Q1 | $138K | Buy |
+14,703
| New | +$138K | 0.01% | 677 |
|